Tsumura &TSUMURA & CO.4540東証プライム医薬品FY ending Mar 2026, consolidated, J-GAAP

Tsumura & FY ending Mar 2020 results

Tsumura & brought in ¥123.2B in revenue.

Out of every ¥100 of sales, about ¥15 is left as operating profit.

Where the money goes

For every ¥100 Tsumura & sells, how much goes where, and how much is kept.

FY ending Mar 2020

Margin funnel (derived from reported values)Gross margin 58.8% → Operating margin 15.3% → Net margin 11.2%

Show source documents (3)

EDINET (FSA Japan)
有価証券報告書－第88期(2023/04/01－2024/03/31)
ID S100TQX72024-06-27Open
EDINET (FSA Japan)
有価証券報告書－第86期(令和3年4月1日－令和4年3月31日)
ID S100OG6Z2022-06-29Open
EDINET (FSA Japan)
有価証券報告書－第85期(令和2年4月1日－令和3年3月31日)
ID S100LRTY2021-06-29Open

Extracted from XBRL: 50 / Derived from other figures: 2

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.